Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG0304

FURIN Knockout HEK293FT Cell Line

  • Product Type:

    Genome-edited Cells

  • Tissue Source:

    Kidney

  • Gene Species:

    Homo sapiens (Human)

The FURIN Knockout HEK293FT Cell Line is a CRISPR/Cas9-edited knockout model in the HEK293FT embryonic kidney host. FURIN encodes a calcium-dependent serine endoprotease that processes proproteins, including TGF-??, insulin receptor, and viral glycoproteins, by cleavage at consensus motifs. This loss-of-function line enables studies of substrate activation, signaling, and viral entry in a high-transfectability background. By disrupting FURIN-mediated cleavage, the model permits investigation of TGF-?? signaling, MT1-MMP-driven invasion, and receptor maturation. Researchers can apply western blotting, pseudoparticle entry, and luciferase reporter assays to define processing-dependent pathways, and produce non-cleavable recombinant proteins.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293FT

    Age

    Fetus

    Sex of Donor

    Female

    Gene Name

    FURIN

    Gene Species

    Homo sapiens (Human)

    Gene Identifier

    NCBI Gene ID 5045

  • Culture Conditions

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

    Pathogens

    Cells tested negative for HIV-1, HBV, and HCV.

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The FURIN Knockout HEK293FT Cell Line is a CRISPR/Cas9-edited knockout cell line that eliminates FURIN function in the HEK293FT host. This loss-of-function model enables precise dissection of calcium-dependent serine endoprotease activity in a well-characterized cellular background, disrupting proprotein processing of substrates critical for growth factor signaling and viral infectivity.

The parental HEK293FT line is a highly transfectable, adenovirus 5-transformed human embryonic kidney derivative stably expressing SV40 large T antigen. Widely used for protein expression and viral vector production, its robust growth and manipulability make it an optimal host for knockout-based studies of post-translational processing.

FURIN encodes a trans-Golgi network-resident serine endoprotease that cleaves inactive proproteins at the consensus Arg-X-(Lys/Arg)-Arg motif. This processing step is essential for activation of pro-TGF-??, pro-IGF1R, pro-insulin receptor, and pro-??-NGF, as well as for maturation of MT1-MMP. FURIN expression is upregulated by TGF-??, HIF-1??, STAT6, and IL-13, and its trafficking relies on interaction with PACS-1. By priming viral spike proteins, FURIN facilitates viral entry. Consequently, its knockout impairs TGF-?? signaling, insulin receptor processing, and Notch1 activation, with downstream effects on proliferation, adhesion, and extracellular matrix dynamics.

In HEK293FT cells, removing FURIN activity blocks the constitutive activation of multiple growth factor pathways and compromises viral glycoprotein maturation. This knockout line is thus pertinent for distinguishing FURIN-dependent signaling events, especially given the host’s widespread application in pseudoparticle-based viral entry assays. Additionally, it permits production of non-cleavable recombinant proteins, supporting research into proteolytic regulation of biological activity.

Applications include western blot analysis of proprotein accumulation, RT-qPCR profiling of TGF-?? and insulin receptor-responsive genes, and viral pseudoparticle entry experiments. Immunofluorescence and flow cytometry can assess substrate localization and surface receptor processing, while luciferase reporters quantify signaling outputs. The line is also suited for cancer invasion studies, as MT1-MMP activation is abolished, and for bioproduction of uncleaved protein variants. For further details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)